This article reviews clinical trials that suggest doxy for prep shows high efficacy but that more research is needed. It’s in Clinical Infectious Diseases, a peer reviewed medical journal from Infectious Diseases Society of America published by the Oxford University Press, part of the actual university. I didn’t say that it was a study in and of itself and that it’s not doesn’t disqualify it as evidence in favor of my point. There is some evidence out there, enough to warrant further research.
The parties performing the 2 concluded medical studies in the article where affiliated with USC Medical Center and ANSR, the French HIV foundation. The questionnaire and Model were implemented for the Australian HIV foundation/SF Department of Medicine. Are these the nefarious parties profiting off the increased sales of a generic drug that can be manufactured by any pharmaceutical company and is obtainable for .78/pill?
The CDC sets how a doctor treats these infections. We know of 10 different antibiotics, 4 of which are approved for use against our most common STIs. Chlamydia gets azithromycin+doxycycline, Syphilis gets penicillin, and gonorrhea ceftriaxone+doxycycline OR azithromycin. Those are the choices. You get basically the same thing every time. There is no “switching it up.”
My suggestion that an antibiotic be used to prevent infection in high risk individuals is not at all the same as the administration to every single animal from birth you see in our farming practices.
Doxy daily may help prevent full blown infections of chlamydia and Syphilis by keeping your body so inhospitable to these they don’t get a chance to take hold before your immune system clears it out. We dunno for sure yet. If it never takes hold it’s one less chance to mutate into a resistant strain though.